Health related quality of life utility weights for economic evaluation through different stages of chronic kidney disease: a systematic literature review
Open Access
- 21 September 2020
- journal article
- review article
- Published by Springer Science and Business Media LLC in Health and Quality of Life Outcomes
- Vol. 18 (1), 1-11
- https://doi.org/10.1186/s12955-020-01559-x
Abstract
A Task Force from the International Society of Pharmacoeconomics and Outcomes Research (ISPOR) provides recommendations on how to systematically identify and appraise health state utility (HSU) weights for cost-effectiveness analyses. We applied these recommendations to conduct a systematic review (SR) to identify HSU weights for different stages of chronic kidney disease (CKD), renal replacement therapy (RRT) and complications. MEDLINE® and Embase were searched for interventional and non-interventional studies reporting HSU weights for patients with CKD stages 1–5 or RRT. As per ISPOR Task Force Guidance, study quality criteria, applicability for Health Technology Assessment (HTA) and generalisability to a broad CKD population were used to grade studies as either 1 (recommended), 2 (to be considered if there are no data from grade 1 studies) or 3 (not recommended). A total of 17 grade 1 studies were included in this SR with 51 to 1767 participants, conducted in the UK, USA, Canada, China, Spain, and multiple-countries. Health related quality of life (HRQL) instruments used in the studies included were EQ-5D-3L (10 studies), SF-6D (4 studies), HUI2/HUI3 (1 study), and combinations (2 studies). Although absolute values for HSU weights varied among instruments, HSU weights decreased with CKD severity in a consistent manner across all instruments. This SR identified HSU weights for a range of CKD states and showed that HRQL decreases with CKD progression. Data were available to inform cost-effectiveness analysis in CKD in a number of geographies using instruments acceptable by HTA agencies.Keywords
Funding Information
- AstraZeneca
This publication has 37 references indexed in Scilit:
- Economic Modelling of Chronic Kidney Disease: A Systematic Literature Review to Inform Conceptual Model DesignPharmacoEconomics, 2019
- Identification, Review, and Use of Health State Utilities in Cost-Effectiveness Models: An ISPOR Good Practices for Outcomes Research Task Force ReportValue in Health, 2019
- Comparison of Quality of Life in Patients Undergoing Hemodialysis and Peritoneal Dialysis: a Systematic Review and Meta-AnalysisKidney and Blood Pressure Research, 2017
- Chronic kidney disease: identification and management in primary carePragmatic and Observational Research, 2016
- Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-AnalysisPLOS ONE, 2016
- A Systematic Review and Meta-Analysis of Utility-Based Quality of Life in Chronic Kidney Disease TreatmentsPLoS Medicine, 2012
- THE IMPACT OF DIALYSIS MODALITY ON QUALITY OF LIFE: A SYSTEMATIC REVIEWJournal of Renal Care, 2011
- Understanding and Assessing the Impact of End-Stage Renal Disease on Quality of LifeThe Patient - Patient-Centered Outcomes Research, 2011
- How to write a Cochrane systematic reviewNephrology, 2010
- Preference-Based Quality of Life of Patients on Renal Replacement Therapy: A Systematic Review and Meta-AnalysisValue in Health, 2008